01 July 2004
Weight increase during machine perfusion may be an indicator of organ and, in particular, vascular damage.
C H Wilson, M A Gok, B K Shenton, S Balupuri, A J Gupta, J Asher, D TalbotAnn Transplant 2004; 9(2): 31-32 :: ID: 142786
Abstract
OBJECTIVES: Hypothermic machine perfusion preservation has been shown toimprove the outcome of renal grafts from non-heartbeating donors. We have noticed that organs gain avariable amount of weight during perfusion. METHODS: All grafts, whether used or discarded, were assessedwith respect to their weight gain. Primary outcome measures were the results of viability testing. Secondaryoutcomes were early transplant variables including incidence and duration of delayed graft function andhistological examination of protocol graft biopsies. RESULTS: Weight increase data was available on 97grafts. There were no significant differences in weight gain between kidneys used and discarded (17%vs 20%). 14 patients received grafts which gained over 30% of their initial retrieval weight. There wereno significant differences in secondary outcome measures between this group of recipients and patientswho had received less "waterlogged" kidneys. Histological changes including endothelial inflammationand oedema were observed. CONCLUSIONS: Kidney grafts which have gained over 30% of weight on hypothermicmachine perfusion preservation can be transplanted successfully. Complex interactions between the periodof warm ischaemia, in situ flushing, perfusion pressures and perfusate probably lead to the phenomenonof excessive graft weight gain.
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






